Age at time of event: the patient age ranges from 21 years old to 75 years old with a median age of 55 years.Gender: seven males and 10 females.Literature article: kerr, d.J., young a.M., neoptolemos, j.P., sherman, m., van-geene, p., stanley, a., ferr, d., dobbie, j.W., vincke, b., gilbert, j., el eini, d., dombros, n.And fountzilas, g."prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution".British journal of cancer (1996) 74, 2032-2035.Doi: 10.1038/bjc.1996.672.The device was not returned, and the lot number is unknown; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|
It was reported 17 patients underwent a study in which unknown elastomeric infusor devices were used for intraperitoneal infusion of 5-fluorouracil (5-fu) over 24 hours for peritoneal carcinomas.It was reported that three patients experienced nausea and vomiting, two patients experienced lethargy, two patients experienced anorexia, seven patients experienced abdominal pain, one patient experienced diarrhea and four patients experienced constipation.Treatment for the events was not reported.At the time of this report, the patient outcomes were not reported.No additional information is available.
|